Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: dutton: we are raising our price target to $0.90 per share
I agree in general, but do not lay the entire blame on them. I believe they are doing a job with one arm tied behind their back. I just felt I had to speak when I saw comments being thrown out without having the complete perspective in mind. I'm done.
Share
New Message
Please login to post a reply